Currently out of the existing stock ratings of Jason Bednar, 202 are a BUY (75.37%), 58 are a HOLD (21.64%), 8 are a SELL (2.99%).

Jason Bednar

Work Performance Price Targets & Ratings Chart

Analyst Jason Bednar, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 54.49% that have a potential upside of 24.92% achieved within 156 days.

Jason Bednar’s has documented 560 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVCR, Novocure Ltd at 13-Dec-2024.

Wall Street Analyst Jason Bednar

Analyst best performing recommendations are on VAPO (VAPOTHERM).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 11/3/2022. The price target of $8 was fulfilled within 1 day with a profit of $2.08 (20.63%) receiving and performance score of 206.35.

Average potential price target upside

of $65.84 (21.45%) on ALGN (ALIGN TECHNOLOGY).
of $40.46 (13.38%) on ISRG (INTUITIVE SURGICAL).
of $29.54 (30.4%) on NVCR (NOVOCURE LTD).

ALGN Align Technology BDX Becton Dickinson and Company COO The Cooper Companies . Common Stock HSIC Henry Schein LUNG Pulmonx Corp NVCR Novocure Ltd NVST Envista Holdings Corp SONX Sonendo VAPO Vapotherm VAR Varian Medical Systems VRAY ViewRay XRAY Dentsply Sirona MASI Masimo PDCO Patterson Companies MMSI Merit Medical Systems STE STERIS plc KRMD Repro Med Systems DRTS Alpha Tau Medical Ltd EDAP EDAP TMS SA MDXH MDxHealth SA ADR ISRG Intuitive Surgical

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Michael Ryskin (BAML)